ACCESS Health publishes study in the International Journal of Molecular Sciences
ACCESS Health Chair Dr. William A. Hasetine and Chief Medical Officer Dr. Robert Patarca have co-authored a scientific paper titled, “Bioinformatics Insights on Viral Gene Expression Transactivation: From HIV-1 to SARS-CoV-2” which was published in the International Journal of Molecular Sciences. Abstract: …
ACCESS Health International participates in an UNGA 78 Side Meeting on Pandemic Preparedness
Dr. Krishna Reddy was recently invited to speak at a high-level side meeting of the 78th session of the United Nations General Assembly (UNGA 78) in New York. The side meeting Actualizing a Whole-of-Society Approach in Pandemic Prevention, Preparedness, and Response (PPPR) was …
A Cure For Hepatitis C: Diagnosis And Direct-Acting Antiviral Drugs
This is the fifth installment in my series on progress toward the elimination of Hepatitis C infection and disease. Read more about Hepatitis C in part one, part two , part three, and part four. In previous articles of this series, we’ve discussed several aspects of …
Direct Acting Antiviral Drugs For The Treatment Of Hepatitis C
This is fourth installment in my series on progress toward the elimination of Hepatitis C infection and disease. Read more about Hepatitis C in part one, part two and part three. Figure 1. The direct-acting antiviral targets in the hepatitis C virus replication cycle. …
Hepatitis C, The Disease, Epidemiology, Treatment, Eradication Part 3: United States Epidemiology
Hepatitis C is the leading blood borne infection, and the number one cause of liver disease in the United States. The Center for Disease Control estimates that 2.7 million people in the US are currently living with a chronic Hepatitis C Virus …
Hepatitis C, The Disease, Epidemiology, Treatment, Eradication Part 2: Global Epidemiology
The World Health Organization currently estimates the global burden of Hepatitis C to be between 130 and 170 million people. Ideally, this figure, as well as stratifications by location, age, and gender, would be more precisely determined based on data from community-based …
Hepatitis C, The Disease, Epidemiology, Treatment, Eradication Part 1: The Disease
Hepatitis C is the leading cause of chronic liver disease and liver cancer in the world and affects an estimated 51 million people globally. Though the viral infection is easily diagnosable and treatable, a cure for hepatitis C remains elusive and one …
Hope For A New Treatment On The Horizon For Zika Virus
Researchers from Duke University, UC Berkeley, Purdue University, and elsewhere have made what will likely be a significant breakthrough in drug development to treat Zika Virus infections. They discovered an unusual monoclonal antibody, not of the common immunoglobulin G family, but rather …
Recent Comments